Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-124-CLR1404 imaging in glioblastoma
NCT01898273Phase 2Terminated
- Sponsor
- Cellectar Biosciences
- Start
- Feb 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Iopofosine I-124 in glioblastoma (GBM), sponsored by Cellectar Biosciences. Started Feb 2014; status: terminated.
02
Drugs
Iopofosine I-124
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01898273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898273.